Finance

Lists
GYRE:NASDAQ
Gyre Therapeutics Inc
7,55 US$
0,00%
(0,00) 1D
7,58 US$
+0,40% (+0,030)
Pre-market
Closed: 18 სექ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GYRE...
Mkt. cap
800,55 მლნ.
Avg. vol.
110,17 ათ.
Volume
265,00
52-wk high
9,42 US$
52-wk low
5,44 US$
EPS
-0,20 US$
Beta
2,20
Shares outstanding
106,03 მლნ.
No. of employees
625
Mkt. cap
800,55 მლნ.
Avg. vol.
110,17 ათ.
Volume
265,00
52-wk high
9,42 US$
52-wk low
5,44 US$
EPS
-0,20 US$
Beta
2,20
Shares outstanding
106,03 მლნ.
No. of employees
625
News stories
From web sources and news partners
About Gyre Therapeutics Inc
CEO-
Employees625
Founded1997
Headquartersუინსტონ-სალემი, ჩრდილოეთი კაროლინა, ამერიკის შეერთებული შტატები
Sector-
Websitegyretx.com
Analyst ratings
Based on 2 analysts giving stock ratings to GYRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GYRE in the last 3 months.
Highest
Current 7,55 US$
20,00 US$ (+164,90%)
Average
19,00 US$ (+151,66%)
Lowest
18,00 US$ (+138,41%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
20,00 US$
+164,9%
08/10/2026
Matthew Keller
H.C. Wainwright
Buy
Reiterated
18,00 US$
+138,4%
08/07/2026
Roger Song
Jefferies
Buy
Initiated
16,00 US$
+111,9%
10/10/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
30,56 მლნ.
37,20 მლნ.
24,43 მლნ.
29,10 მლნ.
Cost of goods sold
1,63 მლნ.
1,74 მლნ.
1,23 მლნ.
2,21 მლნ.
Cost of revenue
1,63 მლნ.
1,74 მლნ.
1,23 მლნ.
2,21 მლნ.
Research and development expenses
2,36 მლნ.
4,82 მლნ.
11,48 მლნ.
19,14 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,65 მლნ.
30,52 მლნ.
24,31 მლნ.
21,62 მლნ.
Operating expense
22,01 მლნ.
35,33 მლნ.
35,79 მლნ.
40,76 მლნ.
Total operating expenses
23,64 მლნ.
37,08 მლნ.
37,02 მლნ.
42,97 მლნ.
Operating income
6,93 მლნ.
120,00 ათ.
-12,59 მლნ.
-13,86 მლნ.
Other non operating income
604,00 ათ.
-2,31 მლნ.
244,00 ათ.
-811,00 ათ.
EBT including unusual items
7,63 მლნ.
-66,00 ათ.
-18,03 მლნ.
-14,43 მლნ.
EBT excluding unusual items
7,63 მლნ.
-864,00 ათ.
-11,65 მლნ.
-13,93 მლნ.
Income tax expense
1,69 მლნ.
1,30 მლნ.
549,00 ათ.
-164,00 ათ.
Effective tax rate
22,19%
-1 969,70%
-3,04%
1,14%
Other operating expenses
-
-
-
-
Net income
3,61 მლნ.
-1,72 მლნ.
-10,30 მლნ.
-10,60 მლნ.
Net profit margin
11,81%
-4,63%
-42,16%
-36,44%
Earnings per share
0,03
0,05
-
-
Interest and investment income
100,00 ათ.
1,35 მლნ.
743,00 ათ.
740,00 ათ.
Interest expense
-
-
-
-
Net interest expenses
100,00 ათ.
1,35 მლნ.
743,00 ათ.
740,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
7,58 მლნ.
815,00 ათ.
-11,92 მლნ.
-12,38 მლნ.
Gain or loss from assets sale
1,00 ათ.
2,00 ათ.
16,00 ათ.
2,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები